Abbott shares sank 8% as Q4 revenue of $11.5B missed the $11.8B target, with nutrition sales dropping 8.9% on price ...

Abbott Labs stock drops on sales miss and weak guidance for 2026, analyst cuts price target but maintains rating.

Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, ...

Abbott Laboratories fell on its latest earnings report, but I view this as a buying opportunity. Read the latest analysis on ...

On Thursday, three companies traded on heavy volume, while their stock prices fell by a meaningful amount. GE Aerospace (GE) ...

March Nasdaq 100 E-Mini futures (NQH26) are trending down -0.20% this morning as a lackluster forecast from semiconductor ...

Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings Call Transcript January 22, 2026 Abbott Laboratories reports earnings inline ...

The Morning Bull - US Market Morning Update Friday, Jan, 23 2026 US stock futures are slightly softer this morning, with S&P 500 contracts edging lower by around 0.1%, as investors weigh higher ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks ...

A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, ...

While the pandemic caused some of Abbott's segments to balloon (diagnostics) and others to fall short (medical devices), conditions have largely normalized and Abbott's prospects will again rely ...

Qiagen was the second-best performer, with a weekly return of 16.92%. The 3-star stock has gained 10.76% over the last three ...